Latest / Fringe Radio Network / Wayback Wednesday! The Spirit Molecule with Dr. Rick Strassman (2010) - A View From The Bunker
Transcript
- 0:04Speaker 1: Hi, everybody. It's me, Cinderella X. You are listening to
- 0:08Speaker 1: the Fringe Radio Network. I know I was going to
- 0:13Speaker 1: tell them. Hey, do you have the app? It's the
- 0:16Speaker 1: best way to listen to the Fringe Radio Network. It's safe,
- 0:20Speaker 1: and you don't have to log in to use it,
- 0:22Speaker 1: and it doesn't track you or trace you, and it
- 0:25Speaker 1: sounds beautiful. I know I was going to tell them.
- 0:29Speaker 1: How do you get the app? Just go to fringeradionetwork.com,
- 0:34Speaker 1: right at the top of the page.
- 0:37Speaker 2: I know, Slippers.
- 0:38Speaker 1: We've got to keep cleaning these chimneys.
- 0:46Speaker 3: The Spirit Molecule, now on A View from the Bunker.
- 0:58Speaker 3: The portal to another dimension may be inside your mind, literally.
- 1:04Speaker 3: Our guest today is the author of nearly 30 peer-reviewed
- 1:08Speaker 3: scientific papers. He served as a consultant to the FDA,
- 1:11Speaker 3: VA hospitals, the Social Security Administration, and other state and
- 1:14Speaker 3: local agencies. In 1984, he began a full-time academic position
- 1:18Speaker 3: at the University of New Mexico, where in 1990, he
- 1:21Speaker 3: began the first new U.S. government-approved and funded clinical research
- 1:25Speaker 3: with psychedelic drugs in over 20 years. He's a full-time
- 1:29Speaker 3: writer now and also clinical associate professor of psychiatry at
- 1:33Speaker 3: the University of New Mexico School of Medicine. It's our
- 1:35Speaker 3: honor to welcome Dr. Rick Strassman to our program. Rick,
- 1:38Speaker 3: thank you for joining us.
- 1:40Speaker 2: Well, thanks for having me on your show, Derek.
- 1:41Speaker 3: And I should point out the author of the book, DMT,
- 1:45Speaker 3: The Spirit Molecule, which is something that grabbed Sharon's attention.
- 1:50Speaker 3: And she's the one who recommended that I get in
- 1:52Speaker 3: touch with you. And, of course, your name was familiar
- 1:55Speaker 3: to me, having seen a presentation that cited your work
- 1:58Speaker 3: at a conference in Nashville given by Dr. Michael Bennett. DMT,
- 2:03Speaker 3: the spirit molecule, an intriguing title. Explain the genesis of
- 2:11Speaker 3: that title.
- 2:13Speaker 2: Well, it kind of harkens back to some of my
- 2:16Speaker 2: original motivation in running the study in the first place.
- 2:20Speaker 2: which I began even thinking about in my college years,
- 2:23Speaker 2: my early 20s, late teens, I, for whatever reason, became
- 2:28Speaker 2: interested in the biological basis of mystical or spiritual experiences.
- 2:33Speaker 2: And through a roundabout career and studies and academics and training,
- 2:40Speaker 2: I ended up studying this drug called DMT, which stands
- 2:44Speaker 2: for dimethyltryptamine. It's a chemical cousin of serotonin, also a
- 2:49Speaker 2: chemical cousin of melatonin. And it's an endogenous compound in
- 2:53Speaker 2: the human body. It's made in all of us, especially
- 2:57Speaker 2: in the lung, maybe red blood cells as well, but
- 3:01Speaker 2: especially the lung tissue makes a lot of DMT. It's
- 3:05Speaker 2: also a very common constituent of plants, you know, of
- 3:12Speaker 2: which there are numerous that are used in the Amazon
- 3:16Speaker 2: for their psychedelic effects, spiritual effects. So when I was
- 3:22Speaker 2: positioned adequately to be able to propose a study like
- 3:26Speaker 2: this to the government and to the university, I chose
- 3:30Speaker 2: DMT as the molecule which to focus on. It was endogenous,
- 3:37Speaker 2: which means it occurs naturally. It's quite psychedelic. It's a
- 3:41Speaker 2: short-acting drug, and since I knew my studies would take
- 3:44Speaker 2: place in a hospital, I thought a shorter-acting drug would
- 3:48Speaker 2: be safer to use than, let's say, the longer-acting drugs
- 3:51Speaker 2: like LSD, which could be 8 to 12 hours. So
- 3:53Speaker 2: we did the study, and people had what some might
- 3:55Speaker 2: consider to be spiritual experiences. among others and so when
- 4:13Speaker 2: I was thinking about a title for the book I
- 4:16Speaker 2: was thinking this is a molecule that seems to lead
- 4:20Speaker 2: people to spiritual states of mind so it was kind
- 4:26Speaker 2: of a paradox in a way molecules and spirituality ostensibly
- 4:31Speaker 2: at least matter and spirit are in some conflict perhaps
- 4:38Speaker 2: so I was thinking that the title would address the paradox,
- 4:46Speaker 2: but at the same time serve as a bridge to
- 4:53Speaker 2: try to work towards reconciling the two fields or the
- 4:56Speaker 2: two areas of thought.
- 4:58Speaker 3: It's a paradox that philosophers and theologians have been wrestling
- 5:03Speaker 3: with for probably 5,000 or 6,000 years at least, if
- 5:06Speaker 3: not longer.
- 5:07Speaker 2: If not longer. Sure, sure.
- 5:10Speaker 3: You mentioned that this is something that occurs, DMT occurs
- 5:13Speaker 3: naturally in plants. And has it been used then by
- 5:19Speaker 3: shaman or religious figures or leaders in cultures throughout history?
- 5:28Speaker 2: Well, it's especially been commonly used in Latin America, where
- 5:32Speaker 2: there are quite a few DMT-containing plants out there. There's
- 5:38Speaker 2: the Amazonian brew, which has been gradually making inroads into
- 5:43Speaker 2: the West, both in North America and in Western Europe.
- 5:47Speaker 2: It's called ayahuasca, and it's You know, there's a couple
- 5:51Speaker 2: of Brazilian churches which actually have been using it in
- 5:55Speaker 2: their liturgy for 70, 80 years or so. And two
- 6:00Speaker 2: of them obtained legal permission from either the Supreme Court
- 6:06Speaker 2: of the U.S. or the Oregon Supreme Court to be
- 6:10Speaker 2: able to use ayahuasca in their religious ceremonies. And You know,
- 6:18Speaker 2: the use of ayahuasca has been going on for, I'd say, well,
- 6:24Speaker 2: you know, for many hundreds of years, if not even
- 6:28Speaker 2: thousands of years in Latin America. Also, you know, there
- 6:33Speaker 2: are other plants that contain DMT that the natives in
- 6:38Speaker 2: Latin America use in other preparations other than ayahuasca. You know,
- 6:45Speaker 2: sometimes they use them as snuffs. Sometimes they'll smoke the
- 6:53Speaker 2: powdered leaves or the powdered seeds of these DMT-containing plants.
- 6:59Speaker 2: So they have a long history within the context of
- 7:02Speaker 2: Latin American shamanism.
- 7:07Speaker 3: Used as part of the liturgy now, are they then
- 7:11Speaker 3: used to induce these metaphysical experiences?
- 7:15Speaker 1: Yes.
- 7:16Speaker 2: Yeah, yeah. Well, I've only been to one of the churches.
- 7:20Speaker 2: It's called the UDV, and I went to a ceremony
- 7:22Speaker 2: in Brazil. Also, they can operate legally in Santa Fe,
- 7:25Speaker 2: New Mexico, so I've attended a couple of their ceremonies
- 7:28Speaker 2: as well. Yeah, you know, so they get together in
- 7:32Speaker 2: a big room with the lights on, and there's a leader,
- 7:35Speaker 2: and it's quite, you know, Christian in orientation. There's a
- 7:39Speaker 2: lot of talk about Jesus and love and God and
- 7:42Speaker 2: compassion and humility and service and things like that. And,
- 7:46Speaker 2: you know, they drink ayahuasca in a big, big group.
- 7:49Speaker 2: And they sit quietly, ask questions. You know, there's some singing,
- 7:52Speaker 2: you know, testimonies, those kinds of things, teachings, you know,
- 7:56Speaker 2: from leaders. And, you know, then you break up at
- 8:00Speaker 2: around four hours. You have something to eat. You kind
- 8:03Speaker 2: of schmooze with your neighbor. And, you know, in a
- 8:06Speaker 2: couple hours when all of the effects have resolved, you know,
- 8:12Speaker 2: then you go home.
- 8:14Speaker 3: What sort of effects does this produce, this brew?
- 8:18Speaker 2: Well, it's kind of a slower-acting version of the intravenous DMT,
- 8:23Speaker 2: which is the compound I used for my study. It's interesting.
- 8:28Speaker 2: The Amazonian natives stumbled upon this combination of plants to
- 8:36Speaker 2: provide an orally active DMT preparation. If you just swallow
- 8:41Speaker 2: pure DMT by itself, it's inactive because of the enzymes
- 8:47Speaker 2: in the stomach that break it down. And so that's
- 8:49Speaker 2: the reason that we gave it intravenously. It's smoked on
- 8:54Speaker 2: the street, but smoking a drug like that in a
- 8:57Speaker 2: hospital for a clinical research study just wasn't practical. So
- 9:02Speaker 2: we gave it intravenously. But by some strange, you know,
- 9:07Speaker 2: feat of... of chemistry, the natives in Latin America, they
- 9:14Speaker 2: found a plant which, if it's combined with another plant
- 9:20Speaker 2: that has DMT in it, the first plant prevents the
- 9:24Speaker 2: breakdown of DMT in the stomach, and it allows the
- 9:28Speaker 2: DMT to be orally active. If you give intravenous DMT,
- 9:34Speaker 2: the effects begin within a few heartbeats. And they peak
- 9:38Speaker 2: within about a minute or two and are, you know,
- 9:40Speaker 2: pretty much gone within 20, you know, to 30 minutes.
- 9:44Speaker 2: When you drink ayahuasca, you know, the effects come on
- 9:47Speaker 2: in about a half hour to an hour. They peak
- 9:50Speaker 2: in about, you know, in around two hours or so
- 9:54Speaker 2: and are, you know, fairly much resolved at around the
- 9:58Speaker 2: four-hour point, you know. but qualitatively, you know, they're quite similar.
- 10:03Speaker 2: It's just a time course, you know, that's so radically different.
- 10:09Speaker 3: When you went looking for a molecule or a substance
- 10:13Speaker 3: to test, to research for these bacteria, effects, something that
- 10:20Speaker 3: would appear to trigger these spiritual experiences. Did you look
- 10:28Speaker 3: specifically for something that was already present in the human body?
- 10:33Speaker 2: Well, you know, I was interested in drugs like LSD
- 10:37Speaker 2: or psilocybin, which is contained in so-called magic mushrooms. You know,
- 10:47Speaker 2: DMT had been studied before, and it was still a
- 10:52Speaker 2: pretty obscure drug. I didn't think it would attract, you know,
- 11:00Speaker 2: the potential amount of, you know, publicity that a more
- 11:04Speaker 2: infamous compound like LSD might. And, you know, its existence
- 11:12Speaker 2: in the human body, you know, obviously called for, you
- 11:18Speaker 2: So that was one of the positive factors that induced
- 11:22Speaker 2: me to look specifically at DMT. It was relatively obscure.
- 11:28Speaker 2: It had been studied safely in humans in previous research,
- 11:32Speaker 2: and it was endogenous. And the reason for its existence
- 11:36Speaker 2: in the human being obviously needed to be studied. Well,
- 11:43Speaker 2: when people first discovered DMT in the human body, I'm
- 11:49Speaker 2: obviously the group that was most interested in its existence
- 11:56Speaker 2: were psychiatrists who were looking for the cause of schizophrenia.
- 12:01Speaker 2: Because there is some overlap between mystical states and psychotic states,
- 12:07Speaker 2: seeing things and distortions of self-image and bodily integrity, those
- 12:14Speaker 2: kinds of things. So instead of looking for a potential
- 12:21Speaker 2: role of DMT in spiritual states, psychiatry looked for DMT's
- 12:25Speaker 2: potential role in psychosis. So that was kind of the
- 12:29Speaker 2: emphasis up until the time all of this research ended
- 12:33Speaker 2: in the early 1970s.
- 12:36Speaker 3: So the presence of DMT in the body then, the
- 12:42Speaker 3: theory then going in, was it to consider how and
- 12:46Speaker 3: whether DMT might, and just to clarify, because I think
- 12:50Speaker 3: you've already alluded to this, but just to clarify, the
- 12:53Speaker 3: theory then to determine how and whether DMT might be
- 12:58Speaker 3: linked to what people report as mystical, supernatural experiences.
- 13:04Speaker 2: Yeah, well, you know, accessibly, the study was a, a
- 13:18Speaker 2: psychopharmacological study of DMT. I got, you know, my funding,
- 13:26Speaker 2: you know, from the National Institute of Drug Abuse, you know,
- 13:28Speaker 2: which is a, you know, division of the National Institutes
- 13:33Speaker 2: of Health. You know, so the study had to be,
- 13:36Speaker 2: you know, presented in a, you know, fairly sober manner.
- 13:43Speaker 2: You know, so am I Well, so the study proposed
- 13:49Speaker 2: to just characterize as many DMT effects as I possibly could,
- 13:56Speaker 2: from the pharmacological to the endocrinological to the psychological. So
- 14:09Speaker 2: in terms of the endocrinological and the pharmacological, effects of DMT.
- 14:17Speaker 2: I was coming at death from the perspective of the
- 14:20Speaker 2: serotonin receptor system in the brain and on the endocrine glands.
- 14:25Speaker 2: You know, from the psychological point of view, I developed
- 14:29Speaker 2: a new rating scale to quantify the effects of DMT.
- 14:33Speaker 2: And also, I took very careful notes on everybody's experiences,
- 14:37Speaker 2: which is something that the short duration allowed me to do.
- 14:40Speaker 2: I was able to write down everything they said and
- 14:42Speaker 2: everything on every move they made and on everything that
- 14:45Speaker 2: went on in the room during that half hour period.
- 14:49Speaker 3: Yeah. Which again, with a longer duration drug like LSD
- 14:52Speaker 3: would have made it very impractical and possibly even, uh,
- 14:56Speaker 3: a little more dangerous, uh, to, uh, to do as, uh, um, the,
- 15:01Speaker 3: the CIA's experimentation with the drug and the search for
- 15:04Speaker 3: the Manchurian candidate, uh, has shown.
- 15:07Speaker 1: Oh yeah. Yeah.
- 15:08Speaker 3: Well, yeah.
- 15:08Speaker 2: And you know, if you have an eight hour drug
- 15:10Speaker 2: or 10 hour drug in a little hospital room, you're
- 15:12Speaker 2: asking for trouble too. So, um, you know, this is
- 15:15Speaker 2: over in a half hour. Um, it was in an
- 15:17Speaker 2: hour and you know, no time at all. The, you know,
- 15:20Speaker 2: and you know, so in terms of, you know, the
- 15:23Speaker 2: psychological effects, that's obviously, you know, where the, where the
- 15:27Speaker 2: majority of, you know, my interests lie. And, uh, I
- 15:31Speaker 2: was looking for experiences from the volunteers that were similar
- 15:42Speaker 2: to those that would be reported by what I believed
- 15:48Speaker 2: would be spiritual types of experiences.
- 15:53Speaker 3: So what were some of the common experiences that people
- 15:56Speaker 3: reported as part of the study you conducted at the
- 15:58Speaker 3: University of New Mexico?
- 16:03Speaker 2: Well, I gave a number of different doses of the drug.
- 16:07Speaker 2: So let me just kind of talk about the higher
- 16:09Speaker 2: doses of the drug because I see where the action was. Yeah, well,
- 16:15Speaker 2: as I mentioned earlier, it begins very quickly within a
- 16:18Speaker 2: few heartbeats. And there's this internal pressure that builds up
- 16:23Speaker 2: at the same time as a high-pitched kind of whining sound,
- 16:27Speaker 2: screeching sound, And as this, you know, sound builds up,
- 16:33Speaker 2: it kind of, you know, reaches a crescendo, kind of
- 16:37Speaker 2: a climax, as it were. And then people burst out
- 16:40Speaker 2: of their bodies or, you know, their consciousness, you know,
- 16:42Speaker 2: seems to dissociate from their physical bodies. You know, as
- 16:47Speaker 2: they're entering into the state, there's quite a kaleidoscopic display
- 16:52Speaker 2: of colors going on, either with their eyes open or
- 16:54Speaker 2: their eyes closed. it was a little distracting for people
- 16:59Speaker 2: to open up their eyes in the beginning of the experience,
- 17:02Speaker 2: you know, so I had to encourage people to keep
- 17:04Speaker 2: their eyes closed. And actually after a few months of
- 17:08Speaker 2: getting things underway, we actually encouraged people to use black
- 17:14Speaker 2: eye shades, you know, to cover their eyes, you know,
- 17:16Speaker 2: so if they did open their eyes reflexively, you know,
- 17:20Speaker 2: they'd be reminded to keep their eyes closed. Um, You know,
- 17:23Speaker 2: so at about the one-minute point or, you know, the
- 17:26Speaker 2: half-minute point, you know, people's consciousness would kind of leave
- 17:29Speaker 2: their bodies, and there would be disembodied consciousness, you know,
- 17:35Speaker 2: perceiving this on a very ecstatically, emotionally-laden world of light.
- 17:46Speaker 2: You know, it could be, you know, some of the visual...
- 17:53Speaker 2: images could be more, you know, simply unformed geometric patterns,
- 17:58Speaker 2: but oftentimes these patterns coalesced into images of beings, insect-like, plant-like, serpentine-like, angelic,
- 18:13Speaker 2: you know, sometimes human, you know, sometimes machines, you know, sometimes,
- 18:17Speaker 2: you know, some combination thereof. And there was... an exchange
- 18:22Speaker 2: of information between the volunteer and these beings. There was
- 18:28Speaker 2: a tremendous amount of elation and astonishment at being transported
- 18:34Speaker 2: to this completely independent, seemingly freestanding realm of reality so instantly.
- 18:41Speaker 2: So there was an exchange. exchange of information. There was
- 18:47Speaker 2: an exchange of feelings. Sometimes there was predictions of the future.
- 18:53Speaker 2: Other times, healings took place.
- 18:58Speaker 3: Genuine physical conditions were affected during these altered states?
- 19:05Speaker 2: Well, not physical healings, but psychological healings working through, for example,
- 19:13Speaker 2: post-traumatic stress or depression or creative blocks, those kinds of things.
- 19:24Speaker 3: The beings, was this a consistent experience during the tests,
- 19:30Speaker 3: encountering other entities?
- 19:33Speaker 2: Yeah, it was quite common. I gave close to 60
- 19:38Speaker 2: different people almost 400 different doses of this drug over
- 19:42Speaker 2: the space of of the study which occurred between 1990
- 19:46Speaker 2: and 1995. And I would say over half the people
- 19:51Speaker 2: in the study encountered these kinds of beings.
- 19:55Speaker 3: Were there consistencies in the description of these beings, or
- 19:59Speaker 3: did it really depend on the individual?
- 20:03Speaker 2: You know, it really depended on the individual. You know,
- 20:06Speaker 2: some You know, one thing that was, you know, kind
- 20:08Speaker 2: of common was an insect motif, like a bee or
- 20:12Speaker 2: just a generic insect. It was hard to describe her praying. Or,
- 20:16Speaker 2: you know, something like a praying mantis. Other times it
- 20:26Speaker 2: was like a plant. One guy had an experience of
- 20:28Speaker 2: these big saguaro cactuses interacting with him. You know, sometimes
- 20:33Speaker 2: they were humans. You know, either Indians or Mexicans or,
- 20:38Speaker 2: you know, everyday, you know, kinds of North American types.
- 20:43Speaker 2: You know, sometimes there are machines, computers. You know, sometimes
- 20:48Speaker 2: there are angels. You know, one guy's experience was that
- 20:54Speaker 2: he was in the middle of an apartment, you know,
- 20:57Speaker 2: that was sentient, intelligent, and was alive. You know, so...
- 21:04Speaker 2: You know, as time went on and I was trying
- 21:06Speaker 2: to understand and, you know, make some sense of people's
- 21:10Speaker 2: experiences and the individual nature of the quality of these beings,
- 21:17Speaker 2: it began to, you know, dawn on me that these were,
- 21:21Speaker 2: you know, specific, you know, kinds of information that was
- 21:29Speaker 2: being transmitted in some form or another. And, you know,
- 21:32Speaker 2: the image... that these forces took on seemed resonant with
- 21:41Speaker 2: the type of information that was being exchanged.
- 21:47Speaker 3: How consistent were the messages, the information that the subjects
- 21:52Speaker 3: reported receiving or exchanging with these beings that they encountered?
- 21:58Speaker 2: Well, that's a good question. I think it would kind
- 22:02Speaker 2: of depend on the level of development of the person
- 22:05Speaker 2: himself or herself. If the person was kind of mired
- 22:10Speaker 2: in their own psychology, I was quite careful to screen
- 22:13Speaker 2: out anybody with any major psychological problems or any drug
- 22:17Speaker 2: abuse problems. So it was a psychologically healthy group of volunteers.
- 22:25Speaker 2: But nevertheless, everybody has got their problems. And the ones
- 22:31Speaker 2: that were more concerned on an everyday kind of basis
- 22:36Speaker 2: with their own issues, their own stories, their own problems,
- 22:40Speaker 2: their own interpersonal conflicts, in those cases, the information was
- 22:45Speaker 2: oftentimes psychological in nature. For the ones who had done
- 22:50Speaker 2: more inner work, more spiritual-oriented, had you know, had worked
- 22:55Speaker 2: through a lot of their psychological, you know, conflicts previously.
- 22:59Speaker 2: In those individuals, you know, the messages were more cosmic,
- 23:06Speaker 2: more spiritual, more, you know, well, yeah, I suppose that's a,
- 23:11Speaker 2: you know, you know, those are, you know, good descriptions,
- 23:15Speaker 2: you know, more cosmic, more spiritual, you know, more oriented,
- 23:21Speaker 2: towards divinity and what to do with their lives, those
- 23:24Speaker 2: kinds of issues.
- 23:26Speaker 3: What was the, how to phrase this, theological or philosophical
- 23:31Speaker 3: orientation of the group? I mean, did you screen for, say,
- 23:35Speaker 3: people who came in convinced that we were being visited
- 23:38Speaker 3: by extraterrestrials or convinced that, well, any particular political or
- 23:51Speaker 3: bent or philosophical bent or, or were you, did you
- 23:54Speaker 3: pretty much just focus on a, uh, looking for people
- 23:58Speaker 3: who seem to be, uh, in your opinion, well grounded and, and, uh, and, uh,
- 24:04Speaker 3: and fairly stable?
- 24:06Speaker 2: Yeah. Um, well, the bottom line was that everybody had
- 24:10Speaker 2: experience with these drugs before in some, in, you know,
- 24:13Speaker 2: some form or another. Um, you know, in, uh, You know,
- 24:18Speaker 2: it was the first such study like this in a
- 24:23Speaker 2: long time in the States, and I was extremely concerned
- 24:28Speaker 2: about safety, informed consent, those kinds of things. And so
- 24:32Speaker 2: the first screening question I asked any prospective volunteer was
- 24:37Speaker 2: if they had experience with these drugs before. And then
- 24:41Speaker 2: I would ask what kind of experiences and if they
- 24:44Speaker 2: seemed to be handy. the prospective volunteer seemed to be
- 24:49Speaker 2: able to handle the responses to these drugs. And so
- 24:56Speaker 2: after that, I just screened them for psychological and physical health.
- 25:05Speaker 2: The majority, I would say almost all of the volunteers,
- 25:10Speaker 2: were interested in things like meditation, Eastern religion, Buddhism, those
- 25:15Speaker 2: kinds of things. And actually, I was coming at it
- 25:18Speaker 2: from that perspective, too, from the theological point of view.
- 25:26Speaker 2: I was raised Jewish, but kind of abandoned it in
- 25:30Speaker 2: my teens. And then in my late teens and early twenties,
- 25:36Speaker 2: I became interested in Zen Buddhism, which I pursued. you know,
- 25:44Speaker 2: fairly rigorously for over 20 years after that. You know,
- 25:50Speaker 2: there weren't any, you know, devout either Jews or Christians
- 25:53Speaker 2: in my study. You know, there were some pagans, you know,
- 25:58Speaker 2: some followers of the Wiccan religion. You know, I'm often
- 26:03Speaker 2: asked if the whole UFO alien thing was implanted in them,
- 26:08Speaker 2: you know, because of the larger culture's interest in abductions
- 26:11Speaker 2: and so on, but... My studies took place in the
- 26:16Speaker 2: early 90s. Much of this thought and interest in UFOs
- 26:23Speaker 2: and entities and beings was all that popular. Actually, a
- 26:28Speaker 2: number of the volunteers, after they had these experiences, were
- 26:33Speaker 2: quite surprised and thought, well, I have no interest in
- 26:37Speaker 2: this stuff.
- 26:37Speaker 3: Why?
- 26:39Speaker 2: Why am I having these kinds of experiences if I'm
- 26:42Speaker 2: not interested? I've never read anything about beings. But I
- 26:48Speaker 2: think that these things have to take some kind of form.
- 26:51Speaker 2: They have to put on some kind of garments for
- 26:56Speaker 2: us to be able to see them. So I think
- 26:59Speaker 2: that they were taking on whatever form the person... was
- 27:05Speaker 2: comfortable with seeing or was kind of constructed out of
- 27:10Speaker 2: bits and pieces of their unconscious to be able to
- 27:14Speaker 2: manifest in some way that they were visible and perceptible.
- 27:19Speaker 3: Well, let me ask you this then. Do you think
- 27:23Speaker 3: that what these people were seeing were constructs of their
- 27:25Speaker 3: own minds, or were they actually seeing something that was,
- 27:29Speaker 3: as you say, putting on a form of that would
- 27:32Speaker 3: be recognizable to the human consciousness in order to communicate?
- 27:38Speaker 2: Well, you know, I think it's kind of a combination.
- 27:43Speaker 2: You know, I spent a lot of time thinking and,
- 27:46Speaker 2: you know, discussing with colleagues, you know, whether, you know,
- 27:54Speaker 2: concerning the location of this realm and the inhabitants or,
- 27:58Speaker 2: you And so despite all of my scientific training and
- 28:12Speaker 2: even Buddhist training, which regards these sorts of phenomena as
- 28:24Speaker 2: mental constructs as well, I ended up on the side
- 28:28Speaker 2: of believing that they're independent things, you know, they're not
- 28:33Speaker 2: in our minds, you know, they're being perceived in our minds,
- 28:35Speaker 2: but they're external to us. Um, and, um, you know,
- 28:40Speaker 2: because they have to be, you know, seeable, um, you know,
- 28:43Speaker 2: that our own minds, uh, kind of, you know, generate, um,
- 28:49Speaker 2: I suppose the clothing or the garments or the, or, um, or,
- 28:56Speaker 2: you or the actual form that they take.
- 29:04Speaker 3: It's fascinating that you would say that. What kind of
- 29:06Speaker 3: reaction have you received? How has it affected you professionally
- 29:12Speaker 3: to come out and say that publicly? I mean, you
- 29:16Speaker 3: make reference to your scientific training, and I think it's
- 29:19Speaker 3: safe to say that something that can't be observed and
- 29:26Speaker 3: measured or quantified through our physical senses, even aided by
- 29:32Speaker 3: certain devices. But something that we cannot physically observe with
- 29:36Speaker 3: our natural senses, by some means, is usually dismissed by
- 29:40Speaker 3: the scientific method. So how has that affected you professionally, personally?
- 29:48Speaker 2: Yeah, well, you know, to answer the question or to
- 29:54Speaker 2: even kind of address the question of subjective experiences, being
- 30:03Speaker 2: the topic of scientific study. I mean, everybody dreams and
- 30:09Speaker 2: everybody believes that there are dreams, but nobody's ever seen
- 30:14Speaker 2: anybody else's dream. Nobody's measured somebody else's dream on a
- 30:18Speaker 2: machine and recorded it for somebody else to look at.
- 30:22Speaker 2: So that's a good example of a common subjective experience.
- 30:27Speaker 2: which is still subject to scientific scrutiny and scientific study.
- 30:33Speaker 2: The contents of the dream aren't obviously studyable in the
- 30:38Speaker 2: same manner that scans of the brain and EEGs can be.
- 30:46Speaker 2: But still, everybody acknowledges that there is a dream state.
- 30:49Speaker 2: Everybody dreams. So I'm kind of proposing in a way
- 30:53Speaker 2: that But I guess it's slightly more radical, you know,
- 30:58Speaker 2: because everybody believes that dreams are generated, you know, from
- 31:02Speaker 2: within the brain or within the mind. And I'm, you know,
- 31:05Speaker 2: more proposing, you know, that this is just a mental
- 31:08Speaker 2: perception of, you know, something that is out there as
- 31:11Speaker 2: opposed to being internally generated. You know, well, I can
- 31:18Speaker 2: answer both questions. You know, you know, It also could
- 31:24Speaker 2: be the case in a few hundred years that we
- 31:26Speaker 2: are able to photograph somebody's dreams or we are able
- 31:31Speaker 2: to photograph what's going on in the DMT state. So
- 31:36Speaker 2: we can turn it into some objective data. But our
- 31:42Speaker 2: scientific technology is incapable at this point of being able
- 31:47Speaker 2: to record those kind of data. And, you know, in
- 31:53Speaker 2: terms of the professional fallout from the book, I kind
- 31:58Speaker 2: of hedged my bets in the DMT book, which I
- 32:01Speaker 2: wrote in the late 90s. I stopped working at the
- 32:05Speaker 2: university in 1995. I had just given too much DMT,
- 32:10Speaker 2: and I wasn't able to understand what people were going through. And,
- 32:14Speaker 2: you know, on the ad, you know, I... first began
- 32:21Speaker 2: studying a group of friends and colleagues, and then as
- 32:24Speaker 2: time went on, I was recruiting people that I really
- 32:30Speaker 2: didn't know that well. So even though nobody really had
- 32:34Speaker 2: a terrible time, I was still increasingly concerned that I
- 32:42Speaker 2: might not have been doing all that much good for
- 32:47Speaker 2: people Because I couldn't really understand what it was they
- 32:50Speaker 2: were going through. Was this their brain on drugs? Was
- 32:57Speaker 2: it some kind of psychological aberration? Were people being thrust
- 33:02Speaker 2: into some alternative dimensions of reality that somehow this compound
- 33:09Speaker 2: was allowing access to? So I was getting confused as
- 33:13Speaker 2: to what exactly I was doing and what it all meant.
- 33:16Speaker 2: So by the time my grants were about done, there
- 33:23Speaker 2: were a number of other more personal and familial issues
- 33:30Speaker 2: that also had to be taken care of at the time.
- 33:32Speaker 3: So I....
- 33:35Speaker 2: Stopped working at the university and, you know, packed up
- 33:38Speaker 2: shop with the research effort in around 1995. You know,
- 33:42Speaker 2: you know, so since then, um, I've either been just,
- 33:44Speaker 2: you know, doing clinical psychiatry in a practice, um, or else, um,
- 33:49Speaker 2: I've been writing. Um, I don't have any, uh, you know,
- 33:52Speaker 2: permits or any grants, you know, from the government. Um,
- 33:55Speaker 2: at this point, um, I'm not doing, um, any clinical research, um, anymore,
- 34:00Speaker 2: you know, so I have a lot more, uh, latitude
- 34:06Speaker 2: and freedom to speculate about some of these findings and
- 34:13Speaker 2: some of their implications.
- 34:15Speaker 3: Now, the study at the University of New Mexico between
- 34:17Speaker 3: 1990 and about 1995, is that correct? Right. Okay, so
- 34:21Speaker 3: that was pre-X-file, so maybe the cultural indoctrination, or however
- 34:27Speaker 3: you want to phrase it, into alien graves, maybe not
- 34:30Speaker 3: as strong, as pervasive as it is today.
- 34:34Speaker 2: No, no, I don't think so. And, you know, strangely enough,
- 34:40Speaker 2: of all those entities that my volunteers saw, you know,
- 34:45Speaker 2: not one of them was your typical, you know, little gray,
- 34:51Speaker 2: you know, with a small mouth and, you know, the
- 34:53Speaker 2: large head.
- 34:54Speaker 3: Well, what was it that led them to conclude or
- 34:55Speaker 3: at least speculate that these were alien entities that they
- 34:59Speaker 3: were encountering?
- 35:01Speaker 2: Oh, well, you know, alien entities is, you know, it's
- 35:05Speaker 2: a convenient term.
- 35:07Speaker 3: It's a catch-all phrase, right.
- 35:08Speaker 2: Yeah, you know, it's kind of like a guy or
- 35:11Speaker 2: a gal, you know. It's an easy description, you know,
- 35:16Speaker 2: to capture something that could be, you know, fairly subtle.
- 35:20Speaker 2: You know, so people really didn't call them aliens all
- 35:23Speaker 2: that much. You know, they called them plants or bees
- 35:26Speaker 2: or insects or machines or those kinds of things. And,
- 35:31Speaker 2: you know, when I was writing the book, I was
- 35:36Speaker 2: struggling about what to call them, and I ended up
- 35:39Speaker 2: just calling them beings. That was the most generic term
- 35:42Speaker 2: I could come up with.
- 35:44Speaker 3: Did they give any kind of indication as to their
- 35:47Speaker 3: nature or their origins?
- 35:50Speaker 2: Well, you know, when they did talk about it, you know,
- 35:54Speaker 2: they did refer... to being from some other place, some
- 36:04Speaker 2: other planet, some other solar system, some other distant celestial body.
- 36:12Speaker 2: That wasn't all that common, though, that they actually said,
- 36:15Speaker 2: this is who we are. They were more kind of
- 36:18Speaker 2: interested in you know, doing things or, you know, getting certain, uh,
- 36:23Speaker 2: you know, points across as quickly as they could, you know,
- 36:26Speaker 2: because the time was limited just a few minutes in
- 36:28Speaker 2: real time.
- 36:29Speaker 3: Because of the, uh, quick acting nature of the DMT molecule.
- 36:33Speaker 1: Yeah. Yeah.
- 36:34Speaker 3: Yeah.
- 36:34Speaker 2: You know, in terms of clock time, you know, uh, um,
- 36:40Speaker 2: you know, the meat of the experience took place probably
- 36:43Speaker 2: just over the space for that, you know, maybe 10
- 36:46Speaker 2: minutes or less.
- 36:48Speaker 3: Subjectively to the, uh, people in the experiment, how long
- 36:51Speaker 3: did that 10 minutes feel?
- 36:53Speaker 2: Well, it felt, you know, for hours and hours for
- 36:57Speaker 2: some people, you know, some people even, you know, were convinced,
- 37:00Speaker 2: you know, that they had died and, you know, had
- 37:03Speaker 2: come back. Um, and, you know, so in that, you know,
- 37:07Speaker 2: the white light kind of death state, uh, you know,
- 37:10Speaker 2: they just, you know, kind of hovered, you know, uh,
- 37:13Speaker 2: you know, for how, um, ever long it, you know,
- 37:16Speaker 2: seemed to be, it became timeless in, in, you know,
- 37:18Speaker 2: those cases. Hmm.
- 37:21Speaker 3: What's the connection?
- 37:21Speaker 2: You know, but it was interesting. Oftentimes, you know, people
- 37:24Speaker 2: would open up their eyes and, you know, they would ask,
- 37:27Speaker 2: you know, how much time had elapsed. And I'd say, oh,
- 37:29Speaker 2: about 20 minutes or so. And they'd say, 20 minutes?
- 37:32Speaker 2: It seemed like hours and hours and hours. So that
- 37:35Speaker 2: was a fairly common reaction.
- 37:37Speaker 3: Huh. What's the connection between the DMT molecule and the
- 37:42Speaker 3: pineal gland?
- 37:45Speaker 2: Well, the pineal gland, you know, obviously has been an
- 37:48Speaker 2: object of curiosity and even veneration, you know, for thousands
- 37:52Speaker 2: of years. It's, you know, the only unpaired organ in
- 37:56Speaker 2: the brain. You know, the Kabbalists and, you know, the
- 38:00Speaker 2: Hindu esoteric, you know, physiology system, they both place a
- 38:07Speaker 2: lot of merit in the spiritual power of, you know,
- 38:11Speaker 2: the location of the body where the pineal resides, you know,
- 38:14Speaker 2: kind of under the fontanelle of the skull in the human.
- 38:22Speaker 2: So they've speculated that it's the location of the highest
- 38:28Speaker 2: spiritual states which people are capable of attaining. The pineal gland,
- 38:35Speaker 2: it was just kind of a curiosity for medicine up
- 38:42Speaker 2: until the 1940s or so. at which time melatonin was
- 38:48Speaker 2: discovered as, you know, um, uh, skin as a skin,
- 38:53Speaker 2: you know, lightning agent in, um, in, you know, certain,
- 38:56Speaker 2: you know, lizards. Um, and then it was, uh, it
- 39:03Speaker 2: was then studied more carefully in, in, you know, mammals
- 39:07Speaker 2: and it was discovered, you know, to have reproductive, um, effects, um, in, uh,
- 39:13Speaker 2: you know, in terms of, you know, seasonal breeding, uh,
- 39:16Speaker 2: you know, kinds of issues. Um, and it was still
- 39:19Speaker 2: unclear for a little, you know, uh, you know, for
- 39:23Speaker 2: quite some time, what the role of melatonin is in humans. Obviously,
- 39:33Speaker 2: I was interested in the pineal gland as a possible
- 39:38Speaker 2: source or as a location of spiritual experience. In my
- 39:43Speaker 2: library reading, I was able to to determine that there
- 39:50Speaker 2: were quite a few interesting coincidences that had to do
- 39:58Speaker 2: with a pineal gland and its possible role in spiritual experience.
- 40:04Speaker 2: It has quite high concentrations of serotonin, which is one
- 40:13Speaker 2: of the steps in the formation of It has a
- 40:21Speaker 2: number of enzymes which are required for the synthesis of DMT.
- 40:28Speaker 2: And even one small study quite a few years ago
- 40:36Speaker 2: demonstrated if you use pineal tissue in a test tube,
- 40:44Speaker 2: and you mix it in with a number of different chemicals,
- 40:48Speaker 2: you can get a DMT-like chemical that's produced in the
- 40:53Speaker 2: test tube. But despite all of this, we still really
- 40:57Speaker 2: haven't determined if the pineal gland makes DMT or not.
- 41:02Speaker 2: In the DMT book, I do marshal quite a bit
- 41:08Speaker 2: of circumstantial evidence for a potential... pineal location of DMT,
- 41:17Speaker 2: but it still remains to be determined. Even if the
- 41:23Speaker 2: pineal gland doesn't have anything to do with DMT, I
- 41:28Speaker 2: don't think it would necessarily impact the role or the
- 41:36Speaker 2: significance of naturally occurring DMT in naturally occurring spiritual states,
- 41:42Speaker 2: especially especially because the lung is capable of making so
- 42:00Speaker 2: much DMT quite easily.
- 42:03Speaker 3: But the body seems to regulate the level of DMT
- 42:07Speaker 3: in the bloodstream and keeps it to a, I guess,
- 42:11Speaker 3: manageable level.
- 42:13Speaker 2: Yeah, well, that's a very interesting thing. In the 1970s,
- 42:16Speaker 2: there were a couple of Japanese studies that demonstrated that
- 42:22Speaker 2: the brain expends energy getting DMT into its confines. which
- 42:43Speaker 2: is a rare thing. The brain is extremely sensitive to
- 42:50Speaker 2: what's in it, and it has this thing which protects
- 42:53Speaker 2: it called the blood-brain barrier. And it can be extremely
- 42:59Speaker 2: difficult for things to get into the brain through the
- 43:04Speaker 2: blood-brain barrier. And for some crucial components of brain function,
- 43:10Speaker 2: you know, the brain actually expends energy, you know, kind
- 43:13Speaker 2: of pumping it across into the brain through the blood-brain barrier.
- 43:18Speaker 2: And actually, these Japanese studies demonstrated that the brain expends
- 43:26Speaker 2: energy in getting DMT into itself. You know, so it's
- 43:30Speaker 2: almost as if DMT is required for, you know, normal
- 43:33Speaker 2: brain function. You know, there's only a few amino acids
- 43:37Speaker 2: that the brain expends energy on. you know, to get
- 43:40Speaker 2: into itself, you know, glucose, you know, the brain's fuel
- 43:43Speaker 2: is transported across the blood-brain barrier. You know, so DMT
- 43:48Speaker 2: is as well. And it, you know, obviously, you know, it,
- 43:53Speaker 2: you know, kind of raises the question, you know, why
- 43:58Speaker 2: is this the case? So it, you know, it, you know,
- 44:01Speaker 2: could be that DMT is, you know, kind of acting
- 44:05Speaker 2: as a, you know, kind of reality thermostat, you know,
- 44:08Speaker 2: you know for the brain it you know is required
- 44:12Speaker 2: for you know perceptual you know homeostasis as it were
- 44:16Speaker 2: you know too much you know DMT in the brain
- 44:19Speaker 2: and you know and you know things become extremely psychedelic
- 44:23Speaker 2: and very strange and you know it you know could
- 44:27Speaker 2: be the case that not enough DMT would lend itself
- 44:30Speaker 2: to kind of a flattening and a graying of you
- 44:34Speaker 2: know the perceptual you know the perceptual world.
- 44:38Speaker 3: Out there That's an interesting thought.
- 44:41Speaker 2: Yeah, it's a weird one, isn't it?
- 44:43Speaker 3: Well, it is. I've been a sci-fi fan for many,
- 44:46Speaker 3: many years and write a little bit, and that prompts
- 44:50Speaker 3: all kinds of little nubs of story ideas. But the
- 44:57Speaker 3: question that presents itself, if what these people are seeing
- 45:01Speaker 3: when the DMT levels rise, are elevated through the intravenous
- 45:07Speaker 3: application or injection of or introduction of DMT into the
- 45:12Speaker 3: bloodstream intravenously. You mentioned that for most of the participants,
- 45:18Speaker 3: you had them close their eyes because it was very distracting.
- 45:22Speaker 3: Were they still seeing the physical world of the hospital room,
- 45:27Speaker 3: the test setting, and this heightened perception that overlaid this
- 45:32Speaker 3: other reality on top of it?
- 45:34Speaker 2: Yeah, well, the contents of the DMT world were overlaid
- 45:46Speaker 2: on the hospital room. Yeah, so that was really a
- 45:50Speaker 2: bit too much. And it was a lot easier if
- 45:53Speaker 2: they just kept their eyes closed.
- 45:55Speaker 3: Wow. So was there any interaction between the DMT world
- 46:01Speaker 3: and the natural world?
- 46:04Speaker 2: Uh, well, I'm like, what do you mean?
- 46:06Speaker 3: I mean, from the viewpoint of someone, uh, under the
- 46:09Speaker 3: influence of DMT, were they seeing anything, um, and not
- 46:15Speaker 3: physical interaction, of course, but did the, uh, I don't
- 46:19Speaker 3: know if you want to call them occupants of this
- 46:21Speaker 3: other realm, the DMT world, did they seem to be
- 46:23Speaker 3: aware of, uh, the occupants of the natural world?
- 46:28Speaker 2: Oh, I see. Were the entities or the beings aware
- 46:32Speaker 2: of the room itself?
- 46:34Speaker 3: Right, right. Yeah.
- 46:34Speaker 2: Well, they told the volunteers, oftentimes in their own ways,
- 46:38Speaker 2: that they were glad that we had stumbled upon this technology. And,
- 46:57Speaker 2: you know, they felt or, you know, relayed to the volunteers,
- 47:01Speaker 2: you know, that they were there all the time and,
- 47:04Speaker 2: you know, separated, you know, from us by an extremely,
- 47:07Speaker 2: you know, thin membrane, obviously, if just within a few heartbeats,
- 47:15Speaker 2: you know, they were there right in front of the volunteers,
- 47:17Speaker 2: you know, you know, consciousness, as it were. And, you know...
- 47:25Speaker 2: sometimes the beings referred to us as the experimenters or
- 47:29Speaker 2: the research scientists. And they would make comments about us.
- 47:35Speaker 2: But that was a small percentage of the content which
- 47:44Speaker 2: was exchanged. So they didn't say, oh, you know, Rick
- 47:49Speaker 2: is picking his nose right now. Or, you know, there's
- 47:54Speaker 2: a cardiogram that's walking down the hall. Or, you know,
- 47:59Speaker 2: like an EKG machine that's going down the hall. So
- 48:02Speaker 2: they didn't make comments like that.
- 48:05Speaker 3: Any reports of information exchange that would be considered paranormal?
- 48:13Speaker 3: I mean, for example, things that these entities– shouldn't have
- 48:16Speaker 3: known or there was no explanation for how they could
- 48:19Speaker 3: know information? Like, say, you know, Dr. Strassman has $ 13. 47
- 48:24Speaker 3: in his pocket or something like that.
- 48:26Speaker 2: No, no. Not as far as I can recall, no. No,
- 48:30Speaker 2: you know, well, you know, the volunteers were, you know,
- 48:33Speaker 2: so blown away and, you know, just kind of had
- 48:37Speaker 2: to hold on to their seats. you know, to keep
- 48:40Speaker 2: their eyes open, as it were, to understand what it
- 48:43Speaker 2: was that was going on and, you know, to remember
- 48:45Speaker 2: as much as possible and to keep their cool. You know, oftentimes,
- 48:50Speaker 2: you know, they just weren't able to ask these beings
- 48:53Speaker 2: any questions. And the, you know, kinds of things that
- 48:59Speaker 2: the beings were, you know, saying or, you know, doing,
- 49:02Speaker 2: you know, they weren't that mundane. You know, they were
- 49:06Speaker 2: more personal or more cosmic in nature.
- 49:12Speaker 3: Not resorting to cheap card tricks, in other words, to
- 49:14Speaker 3: impress the participants.
- 49:17Speaker 2: No, no, there are no cheap card tricks. Although, you know,
- 49:21Speaker 2: they had a mischievous air about them, at least, you know, sometimes, or,
- 49:25Speaker 2: you know, some of them did. So, you know, that's
- 49:29Speaker 2: an interesting thing. You know, if you look at these
- 49:32Speaker 2: entities or these beings as, you know, representative of, you know,
- 49:35Speaker 2: pixies and elves and angels that people have been reporting
- 49:38Speaker 2: for thousands of years, You know, oftentimes they're described as,
- 49:42Speaker 2: you know, having, you know, particular, you know, personality, you know, features,
- 49:47Speaker 2: you know, like being, you know, mischievous or, you know, playful,
- 49:53Speaker 2: you know, those kinds of characteristics.
- 49:54Speaker 3: Yeah, I've read reports online from people who have taken this,
- 49:58Speaker 3: have taken DMT, you know, out in the field, presumably smoked.
- 50:03Speaker 3: And elves are a common theme, you know, people reporting,
- 50:08Speaker 3: you know, seeing the elves, meeting the elves, and so forth.
- 50:12Speaker 2: Yeah, yeah, you know, a lot of that, I think,
- 50:16Speaker 2: you know, could relate to Terence McKenna's popularizing of, you know,
- 50:20Speaker 2: DMT in, you know, the mid, you know, 1990s or so,
- 50:24Speaker 2: because he spoke very clearly and, you know, and quite persuasively,
- 50:31Speaker 2: you know, about the, well.
- 50:40Speaker 2: Regarding the astonishing aspects of, you know, the DMT experience
- 50:45Speaker 2: and the importance of, you know, looking into it. And oftentimes,
- 50:48Speaker 2: you know, DMT experiences were those of elves. So I
- 50:58Speaker 2: think by the time the mid, you know, 1990s rolled
- 51:00Speaker 2: around and, you know, Terrence's, you know, you know, descriptions
- 51:06Speaker 2: of his own DMT experiences became, you know, more popular.
- 51:11Speaker 2: I think it was the case that, you know, more
- 51:13Speaker 2: people started, you know, seeing these elf-like things. You know,
- 51:17Speaker 2: we had no elf, you know, or, you know, I
- 51:20Speaker 2: don't think any of our, you know, volunteers actually, you know,
- 51:23Speaker 2: described elves. You know, at the time our studies were
- 51:29Speaker 2: taking place though, Terrence, you uh, stories hadn't gotten much
- 51:35Speaker 2: popularity yet.
- 51:36Speaker 3: Well, you know, that's an interesting point, uh, that the
- 51:39Speaker 3: people in the field might've been, that their visions might've
- 51:43Speaker 3: been affected by the suggestions from Mr. McKenna. Um, and
- 51:47Speaker 3: you mentioned how you selected, uh, volunteers for the study
- 51:51Speaker 3: based on, uh, some having some experience with psychedelic drugs, which, uh,
- 51:56Speaker 3: probably precluded the, uh, say, devout Christians or Jews, any
- 52:00Speaker 3: devout Christians or Jews participating in your study, because they
- 52:03Speaker 3: would be less likely, one would assume, to have experimented
- 52:06Speaker 3: with those types of drugs. How did that affect, do
- 52:11Speaker 3: you think, the experiences that your volunteers reported? I mean,
- 52:16Speaker 3: was there a, do you think a, let me rephrase that,
- 52:21Speaker 3: would the experiences reported, do you think, might have been
- 52:25Speaker 3: different if you had had devout Christians, Jews, or Muslims
- 52:29Speaker 3: in the study?
- 52:31Speaker 2: Yeah, I'm not sure. And, you know, one of the
- 52:37Speaker 2: reasons that I've actually become interested in the concept of
- 52:42Speaker 2: Old Testament, you know, of the descriptions of the experiences
- 52:51Speaker 2: of the Old Testament prophets is is, you know, because
- 52:59Speaker 2: of the nature of the experiences that, you know, that
- 53:03Speaker 2: my volunteers, you know, had on DMT were not consistent with,
- 53:10Speaker 2: you know, with the kinds of expectations, you know, that
- 53:15Speaker 2: I had and, you know, that the volunteers had coming
- 53:19Speaker 2: from the perspective of, you Eastern religions, especially, you know, Buddhism,
- 53:25Speaker 2: you know, they were expecting, and I was too, you know,
- 53:29Speaker 2: more unitive kinds of, you know, mystical experiences, you know,
- 53:35Speaker 2: the dissolving of the ego into the white light, you know,
- 53:39Speaker 2: the loss of.
- 53:40Speaker 3: Becoming one with the universe, that sort of thing?
- 53:42Speaker 2: Yeah, yeah, you know, the unitive, you know, kinds of
- 53:45Speaker 2: merging experiences. But instead, Instead, almost everybody in my study
- 53:50Speaker 2: had relational experiences. They kept their identity. They were themselves
- 53:58Speaker 2: interacting with these things that were out there, which was
- 54:01Speaker 2: completely different than either my expectations or the vast majority
- 54:09Speaker 2: of the volunteers' expectations. So after the study was done
- 54:16Speaker 2: and I was looking... you know, and I was looking
- 54:21Speaker 2: for some model to explain the spiritual responses, you know,
- 54:29Speaker 2: to this drug. I, you know, I looked quite carefully
- 54:39Speaker 2: at the, you know, Buddhist, you know, paradigmatic spiritual experience
- 54:44Speaker 2: of enlightenment and compared it, you know, to my volunteers' experiences,
- 54:50Speaker 2: and it just, you know, there wasn't much overlap or similarities.
- 55:00Speaker 2: So I then started looking for other systems of spirituality
- 55:07Speaker 2: that took into account the relational nature of the spiritual
- 55:14Speaker 2: world and also its external freestanding reality basis, too. So that's,
- 55:20Speaker 2: you know, so that's when I started, you know, to
- 55:25Speaker 2: look into the Old Testament as, you know, the scripture,
- 55:29Speaker 2: you know, the sacred scripture, you know, from my own background.
- 55:33Speaker 2: And then as, you know, time went on, the whole,
- 55:36Speaker 2: you know, the concept of the prophetic state began to
- 55:50Speaker 2: emerge as a good model to explain and contain and
- 55:55Speaker 2: even kind of build upon the results of my work.
- 56:01Speaker 3: So you're saying then, and please correct me if I'm
- 56:07Speaker 3: wrong because I don't want to misrepresent your position here
- 56:09Speaker 3: or your analysis, but you found that the Old Testament
- 56:17Speaker 3: model of the interaction of the prophets with angels and
- 56:21Speaker 3: perhaps demons, which are angelic beings of a different allegiance,
- 56:28Speaker 3: to be more consistent with the experiences of your volunteers
- 56:32Speaker 3: under the influence of DMT than sort of the mystical
- 56:39Speaker 3: experience of enlightenment that you had thought you'd find?
- 56:42Speaker 2: Yeah. That's a good way to summarize it. Yes, exactly.
- 56:47Speaker 3: That's a pretty powerful statement. And when you read some
- 56:58Speaker 3: of the apocalyptic prophecy of writers like Ezekiel or John
- 57:04Speaker 3: the Revelator, yeah, you can really see that. I guess Daniel, too,
- 57:08Speaker 3: in some of the things that he saw.
- 57:10Speaker 2: And Zechariah.
- 57:12Speaker 1: Yes, yes.
- 57:13Speaker 2: And Jeremiah. I mean, all of them had extremely psychedelic
- 57:17Speaker 2: experiences in, in, in interactive, um, emotionally trying, um, you know,
- 57:24Speaker 2: they were blown away. They couldn't make sense of it.
- 57:27Speaker 2: You know, uh, they quaked and they shivered and they
- 57:31Speaker 2: moaned and they didn't, you know, it was inconsistent.
- 57:33Speaker 3: Fell on their faces.
- 57:34Speaker 2: Right.
- 57:35Speaker 1: Yeah.
- 57:35Speaker 3: Just didn't, didn't know how to process what they were seeing. Yeah.
- 57:38Speaker 2: Right. I know.
- 57:39Speaker 1: Yeah.
- 57:41Speaker 2: Wow.
- 57:41Speaker 3: That's, that's a pretty amazing statement. Um, And, again, I
- 57:47Speaker 3: have to ask this again. What sort of response do
- 57:49Speaker 3: you get from fellow academics when you put this idea
- 57:53Speaker 3: out there? Yeah.
- 57:55Speaker 2: Well, you know, I'm out of the academic world, you know,
- 58:01Speaker 2: to a large extent. You know, I'm not, you know,
- 58:04Speaker 2: doing clinical research anymore. I don't go to meetings. I
- 58:08Speaker 2: don't have, you know, any– I don't have much of
- 58:14Speaker 2: a stake in the so-called scientific worldview. I'm a little
- 58:19Speaker 2: more free to kind of roam where the data takes me.
- 58:25Speaker 2: When the DMT book came out in 2000, I get
- 58:30Speaker 2: responses from kids mostly, from 18 to 25 who have
- 58:35Speaker 2: tried DMT or they've been interested in trying it or
- 58:39Speaker 2: they're trying to understand their own experiences. You know, the
- 58:43Speaker 2: academic community has been respectfully, you know, silent, you know,
- 58:48Speaker 2: more or less. They aren't that interested and, you know,
- 58:51Speaker 2: haven't really made all that, you know, all that much
- 58:55Speaker 2: of a commotion. You know, I think as a result of,
- 59:04Speaker 2: you know, the current, you know, books that I'm, you know,
- 59:07Speaker 2: working on right now, kind of tying in my DMT
- 59:12Speaker 2: work with Old Testament material, I think I'm going to
- 59:21Speaker 2: lose a few readers in the hardcore materialistic, psychedelic subculture
- 59:29Speaker 2: out there. But at the same time, I hope to
- 59:32Speaker 2: interest a whole other group of readers, especially those who
- 59:35Speaker 2: have got an interest in the Bible as a spiritual text. Well, yeah,
- 59:38Speaker 2: and that's why.
- 59:53Speaker 3: My, my wife felt so strongly that, uh, needed to
- 59:55Speaker 3: get in touch with you. And once I realized that, uh, again,
- 59:58Speaker 3: your book DMT, the spirit molecule was a significant part
- 1:00:01Speaker 3: of the presentation, a very eyeopening presentation. I thought at
- 1:00:05Speaker 3: the last day's conference in Nashville, uh, regarding the possibility
- 1:00:08Speaker 3: of a portal to other dimensions, spirit dimensions, uh, inside
- 1:00:12Speaker 3: our own heads. Uh, you know, I, there are, there
- 1:00:16Speaker 3: is a small group, uh, within evangelical Christianity that would, uh,
- 1:00:22Speaker 3: I think appreciate your work, um, you know, and, and
- 1:00:28Speaker 3: look at your research as rather groundbreaking. Uh, and most
- 1:00:32Speaker 3: of the, most of the rest of the Christian community
- 1:00:33Speaker 3: thinks we're nuts, frankly. Um, but, uh, so, you know, welcome,
- 1:00:41Speaker 3: welcome to the dark side, but I suppose, uh, in,
- 1:00:44Speaker 3: in the, uh, uh, in the context of your research and, uh, the,
- 1:00:49Speaker 3: the nature of the work that you've been doing, you're
- 1:00:50Speaker 3: kind of used to, uh, stepping out where others fear
- 1:00:54Speaker 3: to tread?
- 1:00:56Speaker 2: Well, yeah, I think, you know, that's just my nature. I,
- 1:01:01Speaker 2: you know, like to break ground and then kind of
- 1:01:03Speaker 2: once it's broken, you know, I kind of look around and,
- 1:01:06Speaker 2: you know, kind of wonder, you know, where is, you know,
- 1:01:10Speaker 2: the next, you know, area that, you know, needs some
- 1:01:15Speaker 2: groundbreaking work done in it. So, you know, I've just
- 1:01:17Speaker 2: been kind of, you know, following... you know, the reports
- 1:01:20Speaker 2: of my volunteers, and it just was not consistent with,
- 1:01:25Speaker 2: you know, the Buddhist point of view, and, you know,
- 1:01:28Speaker 2: explaining it purely from the brain chemistry point of view
- 1:01:31Speaker 2: seemed a little, you know, just, you know, kind of short-sighted.
- 1:01:36Speaker 2: So I think the content of these states are spiritual
- 1:01:41Speaker 2: to a large extent, and I think there ought to
- 1:01:45Speaker 2: be some contextualizing of those experiences from a spiritual perspective
- 1:01:49Speaker 2: that people can relate to and that, you know, keeps
- 1:01:51Speaker 2: to the facts or, you know, to the data anyway of,
- 1:01:54Speaker 2: you know, the descriptions of, you know, people's experiences.
- 1:01:59Speaker 3: Based on what you saw and what you've read since
- 1:02:03Speaker 3: your research concluded at New Mexico back in 1995, what
- 1:02:09Speaker 3: is your view of attempts to contact this spirit realm?
- 1:02:15Speaker 2: Well, you know, you have to be careful what you
- 1:02:18Speaker 2: ask for. And, you know, yeah, yeah. Well, you know,
- 1:02:23Speaker 2: people are always, you know, asking me about, you know,
- 1:02:27Speaker 2: about how to get DMT or, you know, they want
- 1:02:29Speaker 2: to take it and, you know, they want me to
- 1:02:32Speaker 2: give them, you know, some advice about how to take it. And,
- 1:02:36Speaker 2: you know, and, you know, so my, you know, so my...
- 1:02:45Speaker 2: standard answer is, you know, it's an illegal drug. I
- 1:02:50Speaker 2: only gave it in a, you know, in an approved
- 1:02:52Speaker 2: hospital setting with all my permits in order. I don't
- 1:02:56Speaker 2: think anybody ought to take drugs. You know, that's kind
- 1:02:59Speaker 2: of my pat reply. So, you know, that being, you know, said,
- 1:03:05Speaker 2: you know, people are going to take drugs. So, and,
- 1:03:09Speaker 2: you know, they are, you know, and it is tempting
- 1:03:13Speaker 2: to storm heaven, as it were. And, you know, sometimes,
- 1:03:16Speaker 2: you know, these drugs, you know, can, you know, kind
- 1:03:19Speaker 2: of push you into spiritual states, but, uh, you know,
- 1:03:24Speaker 2: you have to really do your homework and you have
- 1:03:26Speaker 2: to be prepared and you have to get as much
- 1:03:28Speaker 2: inner work, you know, done as you can. And you
- 1:03:30Speaker 2: have to understand, you know, uh, the kinds of things
- 1:03:36Speaker 2: that you might be encountering and, you know, kind of,
- 1:03:39Speaker 2: you know, think about how you're going to deal with
- 1:03:41Speaker 2: them and, uh, You know, so that's, you know, kind of,
- 1:03:45Speaker 2: you know, one of the conclusions of this, of the
- 1:03:50Speaker 2: book that I'm currently, you know, working on is if
- 1:03:53Speaker 2: you want to understand your experiences on these drugs and
- 1:03:57Speaker 2: you want to, you know, kind of go in with
- 1:04:00Speaker 2: a framework and a rudder, you know, and if you
- 1:04:05Speaker 2: come from, you know, Judeo-Christian point of view or, you know,
- 1:04:11Speaker 2: culture even, the Bible is a good place to start.
- 1:04:15Speaker 2: If you want to understand your psychedelic experiences and make
- 1:04:22Speaker 2: the most of them.
- 1:04:25Speaker 1: Then.
- 1:04:27Speaker 2: It could be the case that learning about the Bible
- 1:04:33Speaker 2: and the teachings of the prophets would be a lot
- 1:04:39Speaker 2: more would be more helpful than learning about Buddhism and
- 1:04:49Speaker 2: some of their ideas.
- 1:04:51Speaker 3: And I know our time is running short here, but
- 1:04:53Speaker 3: just as a working theory then, is it your view
- 1:04:57Speaker 3: that this perception of this other realm experienced by the prophets,
- 1:05:05Speaker 3: and perhaps if one accepts the creation story literally, Adam
- 1:05:11Speaker 3: and Eve who walked with God and conversed with him
- 1:05:13Speaker 3: on a regular basis, that this molecule, the DMT molecule, was,
- 1:05:20Speaker 3: shall we say, designed as part of our operating system
- 1:05:24Speaker 3: to facilitate that communication?
- 1:05:26Speaker 2: Well, yeah, I do actually. And, you know, if it's
- 1:05:29Speaker 2: not DMT, it's, you know, some other compound in the brain. But,
- 1:05:33Speaker 2: you know, there's got to be some, you know, biological
- 1:05:35Speaker 2: correlate that's, you know, that's taking place. it isn't the cause,
- 1:05:41Speaker 2: but it's just, you know, kind of how it works. So,
- 1:05:44Speaker 2: you know, it might be DMT, you know, um, you know,
- 1:05:47Speaker 2: I think as, you know, time goes on, you know,
- 1:05:50Speaker 2: you know, that we're going to be discovering all kinds of,
- 1:05:53Speaker 2: you know, psychedelic, you know, compounds that the brain's making
- 1:05:55Speaker 2: all the time. So, um, if it's not only DMT
- 1:05:58Speaker 2: or if it's not, you know, DMT, there's going to
- 1:06:00Speaker 2: be other, you know, similar compounds there. But yeah, um,
- 1:06:04Speaker 2: I think that God designed the brain for it to
- 1:06:09Speaker 2: be able to communicate with spirit realms, and these are
- 1:06:15Speaker 2: the mechanisms by which that communication takes place.
- 1:06:20Speaker 3: Dr. Rick Strassman is the author of DMT, The Spirit Molecule,
- 1:06:23Speaker 3: published by Park Street Press. How can people get a copy.
- 1:06:26Speaker 1: Of your book?
- 1:06:27Speaker 2: Oh, you know, if they go onto my website, they
- 1:06:31Speaker 2: can order it from me and I can sign it,
- 1:06:33Speaker 2: you know, for them. It's a little more expensive, you know,
- 1:06:35Speaker 2: than on Amazon. You know, but it's also carried on
- 1:06:37Speaker 2: Amazon and Barnes & Noble and, you know, oftentimes, you know,
- 1:06:41Speaker 2: the big, you know, bookstore chains have got it too,
- 1:06:43Speaker 2: like Borders and, you know, what have you.
- 1:06:45Speaker 3: And the website is rickstrossman, that's S-T-R-A-S-S-M-A-N.com. I'll put a
- 1:06:51Speaker 3: link to that in the show notes at vftb.net. And, Rick,
- 1:06:55Speaker 3: it's been a fascinating hour of conversation. Please keep in
- 1:06:58Speaker 3: touch and let us know as you get close to
- 1:07:00Speaker 3: publication of your new book because that sounds like a
- 1:07:02Speaker 3: fascinating work and certainly want to talk to you about
- 1:07:04Speaker 3: it and read it when it's available.
- 1:07:06Speaker 2: Okay. I'm kind of getting into the more difficult material
- 1:07:13Speaker 2: with the book right now, but I think it ought
- 1:07:15Speaker 2: to be done by the spring and out by the
- 1:07:17Speaker 2: summer or the fall next year.
- 1:07:19Speaker 3: We'll definitely look forward to talking with you again. Rick Strassman,
- 1:07:22Speaker 3: thank you very much for joining us today on View
- 1:07:24Speaker 3: from the Bunker.
- 1:07:25Speaker 1: Okay.
- 1:07:25Speaker 2: Thanks, Derek. It was a pleasure.
- 1:07:26Speaker 3: Look for a link to Dr. Strassman's website in the
- 1:07:28Speaker 3: show notes, which you'll find online at vftb.net. Monday night,
- 1:07:33Speaker 3: that is August 2nd, 2010, Sharon and I will be live,
- 1:07:36Speaker 3: PID Radio Live, on blogtalkradio.com slash PID Radio. That's Monday night,
- 1:07:41Speaker 3: August 2nd, at 7 p.m. Eastern Time, GMT-5. We'll be
- 1:07:45Speaker 3: discussing more 612 stories, where the rubber meets the road
- 1:07:49Speaker 3: in the spiritual war in which we find ourselves. Welcome
- 1:07:52Speaker 3: to the battlefield. We appreciate your interaction via chat room
- 1:07:56Speaker 3: and the telephone, as you can call in the program
- 1:07:58Speaker 3: as we're on the air live, blogtalkradio.com slash pidradio, Monday,
- 1:08:03Speaker 3: August 2nd at 7 p.m. Eastern Time. Coming up Friday,
- 1:08:07Speaker 3: what if the Bible gives us a template of history,
- 1:08:09Speaker 3: a pattern which we can use to predict future events?
- 1:08:13Speaker 3: It's not Bible codes. It's something different. It's called The
- 1:08:17Speaker 3: Template of Time, which is the title of a new
- 1:08:19Speaker 3: book by Tom Paine. And we'll talk to Mr. Paine
- 1:08:21Speaker 3: Friday night on View from the Bunker live on blogtalkradio.com
- 1:08:25Speaker 3: slash PID Radio. Friday night, 10 p.m. Eastern Time. That's GMT-5. Again, blogtalkradio.com
- 1:08:31Speaker 3: slash PID Radio. We welcome your comments, questions, and guest
- 1:08:35Speaker 3: suggestions via email. Send those to radio at peeringintodarkness.com. And
- 1:08:40Speaker 3: until next time, thanks for listening. I'm Derek Gilbert, and
- 1:08:43Speaker 3: this is A View from the Bunker.
- 1:08:58Speaker 2: Thank you. Hi, everybody.
- 1:09:10Speaker 1: It's me, Cinderella X. You are listening to the Fringe
- 1:09:14Speaker 1: Radio Network. I know I was going to tell them, hey,
- 1:09:19Speaker 1: do you.
- 1:09:19Speaker 2: Have the app?
- 1:09:21Speaker 1: It's the best way to listen to the Fringe Radio Network.
- 1:09:24Speaker 1: It's safe, and you don't have to log in to
- 1:09:27Speaker 1: use it, and it doesn't track you or trace you,
- 1:09:30Speaker 1: and it sounds beautiful. I know, I was going to
- 1:09:34Speaker 1: tell them. How do you get the app? Just go
- 1:09:36Speaker 1: to fringeradionetwork.com, right at the top of the page. I know, Slippers,
- 1:09:43Speaker 1: we've got to keep cleaning these chimneys.